Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT02302742

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

Conditions: Breast Cancer, Hereditary Breast and Ovarian Cancer

Sex: All

Healthy volunteers: Yes

Enrollment: 3000

Sponsor: University of Kansas Medical Center

Location: Hays Medical Center Dreiling-Schmidt Cancer Institute Hays Kansas

Summary

PROGECT is a registry for patients with Triple Negative breast cancer (TNBC) or patients who have an identified germline mutations (such as a mutation on the BRCA1 or BRCA2 genes).

Eligibility Criteria

Inclusion criteria include: Triple Negative Breast Cancer * ER/PR \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT02302742). StuddyBuddy aggregates publicly available trial information.